194 related articles for article (PubMed ID: 9123150)
1. Tacrolimus (FK506) proves superior to OKT3 for treating episodes of persistent rejection following intrathoracic transplantation.
Meiser BM; Uberfuhr P; Schulze C; Fuchs A; Mair H; Reichenspurner H; Kreuzer E; Reichart B
Transplant Proc; 1997; 29(1-2):605-6. PubMed ID: 9123150
[No Abstract] [Full Text] [Related]
2. Tacrolimus: a superior agent to OKT3 for treating cases of persistent rejection after intrathoracic transplantation.
Meiser BM; Uberfuhr P; Fuchs A; Schulze C; Nollert G; Mair H; Martin S; Pfeiffer M; Reichenspurner H; Kreuzer E; Reichart B
J Heart Lung Transplant; 1997 Aug; 16(8):795-800. PubMed ID: 9286771
[TBL] [Abstract][Full Text] [Related]
3. Conversion to tacrolimus for acute corticosteroid- and antibody-resistant rejection following kidney transplantation.
Kliem V; Radermacher J; Hiss M; Pethig M; Burg M; Brunkhorst R
Transplant Proc; 1999 Nov; 31(7A):37S-40S. PubMed ID: 10576041
[No Abstract] [Full Text] [Related]
4. Medium-term outcome of tacrolimus immunosuppression following rejection or graft dysfunction in heart transplant patients.
Marcus N; Khaghani A; Burke M; Yacoub M; Banner N
Transplant Proc; 1998 Jun; 30(4):1134-5. PubMed ID: 9636460
[No Abstract] [Full Text] [Related]
5. Early steroid-resistant rejection following orthotopic liver transplantation: new aspects of treatment with FK 506 instead of OKT3?
Dé P; Bechstein WO; Blumhardt G; Lange D; Schattenfroh N; Neuhaus P
Transplant Proc; 1993 Aug; 25(4):2693-4. PubMed ID: 7689279
[No Abstract] [Full Text] [Related]
6. Acute cardiac ongoing rejection: comparison between different strategies.
Forni A; Faggian G; Luciani GB; Lamascese N; Mazzucco A
Transplant Proc; 2001 May; 33(3):2395-7. PubMed ID: 11377573
[No Abstract] [Full Text] [Related]
7. Tacrolimus therapy for refractory renal allograft rejection: experience with steroid withdrawal.
Cronin DC; Bruce DS; Newell KA; Josephson MA; Millis JM; Piper JB; Ruebe M; Kirby M; Thistlethwaite JR; Woodle ES
Transplant Proc; 1997; 29(1-2):307. PubMed ID: 9123010
[No Abstract] [Full Text] [Related]
8. Optimal timing for surveillance endomyocardial biopsies in heart transplant patients receiving antithymocyte globulin induction.
Cantarovich M; de Gruchy S; Forbes C; Marpole D; Elstein E; Magnan C; de Varennes B
Transplant Proc; 1999; 31(1-2):79. PubMed ID: 10083015
[No Abstract] [Full Text] [Related]
9. Benefits of photopheresis in the treatment of heart transplant patients with multiple/refractory rejection.
Dall'Amico R; Montini G; Murer L; Andreetta B; Tursi V; Feltrin G; Guzzi G; Angelini A; Zacchello G; Livi U
Transplant Proc; 1997; 29(1-2):609-11. PubMed ID: 9123152
[No Abstract] [Full Text] [Related]
10. FK506 for primary and rescue therapy following liver transplantation.
Platz KP; Mueller AR; Zytowski M; Lobeck H; Neuhaus P
Transplant Proc; 1998 Jun; 30(4):1409-10. PubMed ID: 9636570
[No Abstract] [Full Text] [Related]
11. Role of protocol biopsies in the treatment of refractory renal allograft rejection with FK 506.
Woodle ES; Thistlethwaite JR; Haas M; Josephson MA; Newell KA; Bruce DS; Millis JM; Piper JB; Charette JI
Transplant Proc; 1996 Apr; 28(2):998-9. PubMed ID: 8623495
[No Abstract] [Full Text] [Related]
12. FK 506 rescue therapy for irreversible airway rejection in heart-lung transplant recipients: report on five cases.
Knoop C; Antoine M; Vachiéry JL; Yernault JC; Estenne M
Transplant Proc; 1994 Dec; 26(6):3240-1. PubMed ID: 7527957
[No Abstract] [Full Text] [Related]
13. How successful is OKT3 rescue therapy for steroid-resistant acute rejection episodes after heart transplantation?
Wagner FM; Reichenspurner H; Uberfuhr P; Kur F; Kaulbach HG; Meiser BM; Ziegler U; Reichart B
J Heart Lung Transplant; 1994; 13(3):438-42; discussion 442-3. PubMed ID: 8061020
[TBL] [Abstract][Full Text] [Related]
14. Antilymphocyte-antibody prophylaxis: review of the adult experience in heart transplantation.
Taylor DO; Kfoury AG; Pisani B; Hammond EH; Renlund DG
Transplant Proc; 1997 Dec; 29(8A):13S-15S. PubMed ID: 9414668
[No Abstract] [Full Text] [Related]
15. Low-dose tacrolimus (FK 506)-based immunosuppressive protocol in living donor renal transplantation.
Kokado Y; Takahara S; Kyo M; Ichimaru N; Toki K; Wang JD; Okuyama A
Transplant Proc; 1999; 31(1-2):1151-4. PubMed ID: 10083515
[No Abstract] [Full Text] [Related]
16. ATG versus OKT3 in the treatment of steroid-resistant rejection following living-related donor renal transplantation.
Uslu A; Tokat Y; Ok E; Unsal A; Ilkgul O; Kaplan H
Transplant Proc; 1997 Nov; 29(7):2805-6. PubMed ID: 9365571
[No Abstract] [Full Text] [Related]
17. Correlation of clinical outcomes after tacrolimus conversion for resistant kidney rejection or cyclosporine toxicity with pathologic staging by the Banff criteria.
Morrissey PE; Gohh R; Shaffer D; Crosson A; Madras PN; Sahyoun AI; Monaco AP
Transplantation; 1997 Mar; 63(6):845-8. PubMed ID: 9089224
[TBL] [Abstract][Full Text] [Related]
18. Initial experience with tacrolimus rescue therapy in OKT3 resistant rejection.
Herget S; Heemann U; Friedrich J; Kribben A; Wagner K; Philipp T
Clin Nephrol; 1996 May; 45(5):352-4. PubMed ID: 8738671
[TBL] [Abstract][Full Text] [Related]
19. Impact of OKT3 treatment for steroid resistant rejection of renal allografts: the long-term outcome at a single center.
Inui M; Tanabe K; Ishikawa N; Tokumoto T; Harano M; Otsubo S; Suzuki K; Goya N; Yagisawa T; Nakazawa H; Fuchinoue S; Toma H
Transplant Proc; 1999 Nov; 31(7):2870-1. PubMed ID: 10578320
[No Abstract] [Full Text] [Related]
20. Efficacy of tacrolimus in the treatment of refractory rejection in heart and lung transplant recipients.
Onsager DR; Canver CC; Jahania MS; Welter D; Michalski M; Hoffman AM; Mentzer RM; Love RB
J Heart Lung Transplant; 1999 May; 18(5):448-55. PubMed ID: 10363689
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
